NPS PHARMACEUTICALS INC
S-3, EX-5.1, 2000-07-19
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: NPS PHARMACEUTICALS INC, S-3, 2000-07-19
Next: NPS PHARMACEUTICALS INC, S-3, EX-23.1, 2000-07-19



<PAGE>

                                                                     EXHIBIT 5.1

                              Opinion of Counsel
                         (includes Consent of Counsel)


                                 July 17, 2000


Ladies and Gentlemen:

     The undersigned ("Counsel") has acted as counsel to NPS Pharmaceuticals,
Inc., a Delaware corporation (the "Company"), in connection with the preparation
and filing of the Registration Statement on Form S-3 (the "Registration
Statement") with the Securities and Exchange Commission (the "Commission"). The
Company is filing this Registration Statement with the Commission under the
Securities Act of 1933, as amended, for the registration of 215,867 shares (the
"Shares") of the Company's common Stock, $0.001 par value per share (the "Common
Stock").

     In rendering the opinion set forth herein, Counsel has made such
investigations of fact and law, and examined such documents and instruments, or
copies thereof established to Counsel's satisfaction to be true and correct
copies thereof, as Counsel has deemed necessary under the circumstances.

     Based upon the foregoing and such other examination of law and fact as
deemed necessary, and in reliance thereon, counsel is of the opinion that, when
issued, the Shares that may be sold pursuant to the Registration Statement will
be legally and validly issued, fully paid, and nonassessable.

     I hereby consent to the filing of this opinion as an exhibit to the
Registration Statement and to the reference to Counsel under the caption "Legal
Matters" in the Prospectus which is a part of the Registration Statement.


                                         Sincerely,



                                         /s/ James U. Jensen

                                         James U. Jensen, Vice President
                                         Corporate Development and Legal Affairs
                                         Utah State Bar No. 1675


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission